ArticleScientific reports2026
Capsule-enhanced hierarchical vision transformers for rare disease classification from medical images.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automated medical image analysis plays a vital role in rare disease detection, yet existing deep learning models often struggle with severe class imbalance, limited labeled data, and subtle morphological variations. To address these challenges, this paper proposes Swin-CapsuleNet, a hybrid architecture that integrates a hierarchical Swin Transformer with capsule-based representations, tailored for rare disease classification. The framework integrates a Swin Transformer backbone for multi-scale contextual feature extraction with a capsule-based classification head that preserves part-whole spatial relationships through dynamic routing. A class-balanced capsule loss is introduced to improve sensitivity toward under-represented disease categories. Extensive experiments conducted on a multi-center rare disease dataset demonstrate that Swin-CapsuleNet consistently outperforms state-of-the-art CNN, transformer, and capsule-based baselines. The proposed model achieves 94.1% accuracy, a 93.2% F1-score, and an AUC of 0.972, while attaining a macro-F1 of 0.899 for rare disease classes. Ablation studies validate the complementary contributions of hierarchical attention, capsule representations, and the proposed loss function. Furthermore, computational analysis shows that Swin-CapsuleNet offers a favorable balance between performance and efficiency, supporting its applicability in real-world clinical decision-support systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.